The latest health and pharmaceuticals industry and company news and analysis from FriedlNews
Page 1/9

Austrian Health and Pharma Headlines

Sandoz Opens EUR 150 Mln Bio-Pharmaceutical Production Centre

Sandoz GmbH, a part of the Novartis concern, officially opened its new bio-pharmaceutical production centre at its branch in Schaftenau in Tyrol. Thanks to investing EUR 150 million (USD 169.9 million) in the BioInject facilities 100 new jobs will be created.

September 17, 2015

The Takeover of Bwin.Party Still Unclear

The Austrian-British gambling company today asked its rival GVC Holdings for the best possible takeover offer. Earlier and GVC aligned their positions concerning the bid at EUR 1.37 billion (USD 1.55 billion).

August 27, 2015

Apeiron is Now Member of Cancer Research Alliance

Apeiron Wien has joined a collaboration with leading pharmaceutical firms regarding cancer research and treatment. The biotechnological company was co-founded by head of the Institute for Molecular Biotechnology of the Academy of Sciences, Josef Penninger.

August 5, 2015

Austrian Subsidiaries of German Merck Get New CEO

Austrian distribution arms of German pharmaceutical firm Merck KGaA i.e. the Vienna-based firms Merck GesmbH, Merck Chemicals and Live Science GesmbH are getting a new helmsman in Matthias Wernicke.

June 30, 2015

Antibiotics Company Nabriva Therapeutics Collects USD 120 Mln from Investors

Viennese biotech firm Nabriva Therapeutics, specialized in antibiotics against resistant bacteria, has collected USD 120 million from investors. The financing process took two tranches, law firm Wolf Theiss, which advised investors together with US firm Cooley, announced on Wednesday.

April 9, 2015

Vamed to Manage First Hospital in China

Vamed is about to establish and manage its first hospital in China - in the provincial capital Haikou on the island of Hainan.

March 30, 2015

Valneva Completes EUR 45 Million Capital Increase

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

February 4, 2015

Pfizer's Agreement To Acquire Baxter’s Portfolio Of Marketed Vaccines Includes Facility in Austria

Pfizer Inc. announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured.

August 1, 2014

Semperit to Realign Rubber Glove Production in Thailand

Listed chemicals group Semperit is realigning its rubber glove production activities in Thailand, i.e. the 50:50 joint venture with the Thai partner Sri Trang which runs a glove plant, Semperit said. The distribution will be realigned as of the turn of 2014 and 2015, while Semperit is also attempting to push through its rights in the JV at court, the company added.

July 18, 2014

Austrian Export Award 2014 for Above-Average Export Commitment

As part of a festive gala evening in Vienna's Museumsquartier, the Austrian Export Prize 2014 has been awarded by the Federal Minister for Science, Research and Economics, Reinhold Mitterlehner, and the President of the Economic Chamber Austria (WKO) Christoph Leitl.

June 26, 2014